≡

Multiplex Assay Kit for Permeability Glycoprotein (Pgp) ,etc. by FLIA (Flow Luminescence Immunoassay)

CD243; ABCB1; ABC20; CLCS; GP170; MDR1; PGY1; P-Glycoprotein; Multidrug resistance protein 1; ATP-Binding Cassette,Sub-Family B(MDR/TAP),Member 1; Colchicin Sensitivity

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Permeability Glycoprotein (Pgp).
No significant cross-reactivity or interference between Permeability Glycoprotein (Pgp) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Permeability Glycoprotein (Pgp) and the recovery rates were calculated by comparing the measured value to the expected amount of Permeability Glycoprotein (Pgp) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 85-92 88
EDTA plasma(n=5) 97-104 101
heparin plasma(n=5) 97-105 101

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Permeability Glycoprotein (Pgp) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Permeability Glycoprotein (Pgp) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Permeability Glycoprotein (Pgp) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 96-105% 83-90% 98-105% 92-102%
EDTA plasma(n=5) 82-99% 84-94% 92-101% 92-99%
heparin plasma(n=5) 82-101% 84-95% 80-95% 83-99%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:Pgp) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Add 200μL analysis buffer solution to each well of the plate for pre-wetting;
2. Preparation of standards, reagents and samples before the experiment;
3. Add 100μL standard or sample to each well, add 10μL magnetic beads, and incubate 120 minutes protect from light at 25°C on shaker;
4. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60 minutes protect from light at 25°C on shaker;
5. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent B, and incubate 30 minutes protect from light at 25°C on shaker;
6. Wash plate once on magnetic frame;
7. Add 100μL sheath fluid, swirl for 10 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
International Forum of Allergy & Rhinology P-glycoprotein promotes epithelial T helper 2–associated cytokine secretion in chronic sinusitis with nasal polyps Onlinelibrary: alr.21316
International Forum of Allergy & Rhinology P‐glycoprotein regulates Staphylococcus aureus enterotoxin B–stimulated interleukin‐5 and thymic stromal lymphopoietin secretion in organotypic mucosal explants PubMed: 26625351
American Journal of Rhinology & Allergy Intact soluble P-glycoprotein is secreted by sinonasal epithelial cells. pubmed:27456593
The Laryngoscope Secreted P-glycoprotein is a noninvasive biomarker of chronic rhinosinusitis pubmed:27577924
Materials Science and Engineering: C Design of colloidal drug carriers of celecoxib for use in treatment of breast cancer and leukemia
Molecular Cancer Chemotherapeutic drugs stimulate the release and recycling of extracellular vesicles to assist cancer cells in developing an urgent chemoresistance Pubmed: 31830995
Catalog No. Related products for research use of Rattus norvegicus (Rat) Organism species Applications (RESEARCH USE ONLY!)
RPB690Ra01 Recombinant Permeability Glycoprotein (Pgp) Positive Control; Immunogen; SDS-PAGE; WB.
PAB690Ra01 Polyclonal Antibody to Permeability Glycoprotein (Pgp) WB; IHC
SEB690Ra ELISA Kit for Permeability Glycoprotein (Pgp) Enzyme-linked immunosorbent assay for Antigen Detection.
CMB690Ra Multiplex Assay Kit for Permeability Glycoprotein (Pgp) ,etc. by CBA (Cytometric Bead Array) FLIA Kit for Antigen Detection.
LMB690Ra Multiplex Assay Kit for Permeability Glycoprotein (Pgp) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.